PAI LIFE SCIENCES INC

SEATTLE, WA · UEI MSMLUCM9DRT6 · CAGE 47SX4

Small businessSmall-business set-aside

SAM.gov registration active · expires May 29, 2027(as of the monthly SAM public extract)

Awarded (5-yr transactions)

$714K

Set-aside awards seen

Latest period end

May 2024

Largest contract awards

75N93019C00028$2.3M
PHASE II - DEVELOPMENT OF A PROPHYLACTIC ONCHOCERCIASIS VACCINE
National Institutes of Health · NAICS 541714 · Sep 2019 – May 2024 · official record ↗
HHSN272201500030C$1.5M
IGF::OT::IGF INHALED DRUG COMBINATION FOR TUBERCULOSIS THERAPY
National Institutes of Health · NAICS 541712 · Sep 2015 – Sep 2019 · official record ↗
75N93022C00004$598K
LATE STAGE ADJUVANT MIMICS BASED ON TLR4 AGONISTS
National Institutes of Health · NAICS 541714 · Jan 2022 – Jan 2024 · official record ↗
75N93019C00008$299K
THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP PRECLINICAL RABBIT IMMUNOGENICITY DATA DEMONSTRATING EFFICACY OF THE SELFADJUVANTINGAND SELF-AMPLIFYING RNA PLATFORM.
National Institutes of Health · NAICS 541715 · May 2019 – Feb 2021 · official record ↗

Is this your company?

Claim it free on GovScout: matched SAM.gov opportunities for your NAICS codes, incumbent intel on every recompete, and monitoring so your SAM registration never lapses.

Claim your profile — free

Public records from FPDS (via USAspending.gov) and SAM.gov. Figures reflect harvested award data and may not be complete; verify against the linked official records. Not an endorsement. Company in the data by mistake or wish to update it? Email support@usegovscout.com.